Rare Diseases
News from the FDA/CDC
CDC updates guidelines for hepatitis outbreak among children
WHO officials expect data within a week from U.K. cases, which may indicate whether the adenovirus is an incidental infection or a more direct...
Latest News
Low butyrylcholinesterase: A possible biomarker of SIDS risk?
The problem with using these data prematurely is that it will unnecessarily alarm parents that their baby will die, and, to make it worse, be...
Guidelines
Myositis guidelines aim to standardize adult and pediatric care
These are the first guidelines on how to manage adult and pediatric patients with idiopathic inflammatory myopathies (IIM).
Conference Coverage
Prior authorizations delay TNF inhibitors for children with JIA
Many patients newly diagnosed with juvenile idiopathic arthritis (JIA) at one academic center over a year had delays in care due to unnecessary...
Commentary
Alarming global rise in pediatric hepatitis: Expert Q&A
For pediatricians, an awareness of the “outbreak” may allow the clinician to extend the typical workup of a child presenting with an undefined,...
Commentary
Could a common cold virus be causing severe hepatitis in kids?
Dr. Wilson presents hypotheses about what might be going on.
Latest News
New data confirm risk of Guillain-Barré with J&J COVID shot
Nearly all individuals who developed GBS after the Janssen vaccine had facial weakness or paralysis, in addition to weakness and decreased...
Latest News
Topical treatment for EB recommended for approval in the EU
“The benefit of Filsuvez is its ability to promote healing of EB partial thickness wounds,” the EMA said in an announcement.
Conference Coverage
Steroids counter ataxia telangiectasia
Red blood cells infused with dexamethasone sodium phosphate delayed symptom progression and improved survival.
From the Journals
JIA disease activity, disability linked to social factors
For patients with polyarticular juvenile idiopathic arthritis, levels of disease activity and disability vary, depending on family income,...
Conference Coverage
Novel drug significantly reduces tics in Tourette syndrome – without side effects
Ecocipam does not lead to weight gain, anxiety, depression, or tardive dyskinesia, compared with placebo – a factor that may lead to better...